Comparative Pharmacology
Head-to-head clinical analysis: ANGELIQ versus BONJESTA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANGELIQ versus BONJESTA.
ANGELIQ vs BONJESTA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Angeliq combines drospirenone, a spironolactone analogue with antimineralocorticoid and antiandrogenic activity, and estradiol, an estrogen that replaces endogenous estrogen and regulates gonadotropin secretion.
Bonjesta (doxylamine/pyridoxine) is a combination of an antihistamine (doxylamine) and vitamin B6 (pyridoxine). Doxylamine centrally inhibits histamine H1 receptors in the vomiting center, reducing nausea and vomiting. Pyridoxine acts as a cofactor in neurotransmitter synthesis, potentially modulating nausea pathways.
One tablet (drospirenone 0.5 mg/estradiol 1 mg) orally once daily.
For nausea and vomiting of pregnancy: 10 mg doxylamine succinate and 10 mg pyridoxine hydrochloride orally at bedtime on an empty stomach; if symptoms are not controlled, increase to 10 mg doxylamine and 10 mg pyridoxine in the morning and 10 mg doxylamine and 10 mg pyridoxine at bedtime, maximum 40 mg doxylamine and 40 mg pyridoxine per day.
None Documented
None Documented
Estradiol: terminal half-life 13-18 hours; Drospirenone: terminal half-life 25-32 hours, allowing once-daily dosing.
Doxylamine: terminal elimination half-life of 10-12 hours; pyridoxine: half-life of 15-20 days (due to tissue binding). Clinically, the half-life supports once-daily dosing at bedtime.
Estradiol: renal (90%) as conjugates (glucuronide and sulfate), fecal (10%). Drospirenone: renal (50%) as inactive metabolites, fecal (50%) as metabolites; less than 1% excreted unchanged.
Renal excretion accounts for approximately 70-80% of the dose, primarily as metabolites (doxylamine metabolites and pyridoxine metabolites), with less than 5% excreted unchanged. Fecal elimination is minimal (<5%).
Category C
Category C
Hormone Replacement Therapy
Hormone Replacement Therapy